Dermata Therapeutics 8K filing
Dermata Therapeutics files 8K with SEC, disclosing changes in leadership and compensation. The filing also includes financial statements and exhibits.
Filed: 2026-05-27 AccNo: 0001493152-26-025441 Size: 293 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits